id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-262311-vdbk50pl	Grant-Kels, Jane M.	Response to “Risks of Hydroxychloroquine use for COVID-19 prophylaxis”	2020-04-26		.txt	text/plain	317	26	50	title: Response to "Risks of Hydroxychloroquine use for COVID-19 prophylaxis" A recent Wall Street Journal article reported data compiled from the Global Rheumatology Alliance (a coalition of rheumatologists) that more than five dozen "people taking hydroxychloroquine and other treatments for chronic rheumatologic diseases have become infected with Covid-19, according to an analysis of emerging data that is a sign the drugs may not protect people from the new coronavirus." 8. Risks of Hydroxychloroquine use for COVID-19 prophylaxis Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial	./cache/cord-262311-vdbk50pl.txt	./txt/cord-262311-vdbk50pl.txt